Prescription drug · ANDA
Potassium Chloride NDC 0615-8442
Potassium chloride 750 mg/1 · Capsule, Extended release · Oral · NCS HealthCare of KY, LLC dba Vangard Labs
NDC codes
FDA NDC Directory| Package NDC | 11-digit (billing) | Package | Copy |
|---|---|---|---|
| 0615-8442-05 | 00615844205 | 15 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-8442-05)Marketed from Oct 7, 2022 | |
| 0615-8442-39 | 00615844239 | 30 CAPSULE, EXTENDED RELEASE in 1 BLISTER PACK (0615-8442-39)Marketed from Oct 7, 2022 |
How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules
Product information
- Brand name (proprietary)
- Potassium Chloride
- Generic name (nonproprietary)
- potassium chloride
- Active ingredients
- Potassium chloride — 750 mg/1
- Dosage form
- Capsule, Extended release
- Route
- Oral
- Product type
- Prescription drug
- Marketing category
- ANDA — Abbreviated New Drug Application (generic)Application ANDA 214686
- Marketing start
- Listing expires
- Other FDA classes
- Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Osmotic Activity (Mechanism)Potassium Compounds (Chemical structure)
- Identifiers
- Product ID 0615-8442_9738e0ef-5d1c-4a9d-8d51-4c5375d0bda8SPL ID 9738e0ef-5d1c-4a9d-8d51-4c5375d0bda8SPL set ID f1791d4f-029a-487f-aee1-fc5be246d0bcRxCUI 312504UNII 660YQ98I10
- Pharmacologic class
- Osmotic Laxative; Potassium Salt
Billing references
What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.
- HCPCS codeNo match
No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.
- NDC on a medical claim
N400615844205followed by a unit qualifier and the quantityPackage 00615-8442-05. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier
Product label
Current FDA label (SPL), effective .
Indications (excerpt from the label)
Potassium chloride extended-release capsules are indicated for the treatment and prophylaxis of hypokalemia in adults and children with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. Potassium chloride extended-release capsules, contain potassium chloride, a potassium salt indicated for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis, in patients for whom dietary management with potassium-rich foods or diuretic dose reduction is insufficient. ( 1 )
Excerpt only. Read the full label for complete information.
Other NDCs under ANDA 214686
Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.
| Product | Strength | Form · route | Labeler | Product NDC |
|---|---|---|---|---|
| Potassium Chloride | Potassium chloride 600 mg/1 | Capsule, Extended releaseOral | Granules Pharmaceuticals Inc | 70010-147 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | Granules Pharmaceuticals Inc | 70010-148 |
| Potassium Chloride | Potassium chloride 600 mg/1 | Capsule, Extended releaseOral | Granules India Ltd | 62207-914 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | Granules India Ltd | 62207-915 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | A-S Medication Solutions | 50090-7469 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | BluePoint Laboratories | 68001-619 |
| Potassium Chloride | Potassium chloride 750 mg/1 | Capsule, Extended releaseOral | REMEDYREPACK INC. | 70518-4050 |